Martin coleads for the Pharmaceuticals &Medical Products Practice globally. He has advised clients across Asia, Europe, and the United States primarily in the pharmaceuticals, medtech, and consumer goods industries.
Martin previously led our pan-industry Organization Practice in Europe, the Middle East, and Africa and initiated a firm-wide special initiative on managing global organisations. The practice spans organisational design, human capital, transformational change, and postmerger integration.
Examples of Martin’s recent client work include the following:
-
leading a multiyear advanced analytics transformation for a leading pharmaceuticals company
- setting the 10-year strategy for a leading EU-based biopharmaceuticals company
- leading a major brand relaunch for a global leading biopharmaceuticals company
- setting the salesforce strategy and go-to-market model for a global medical products company
- leading a multiyear productivity programme (including 2BB, orgisation, supply, and revenue growth) for a market-leading global consumer company
Martin is a board member of Veryday, a leading design company acquired by McKinsey in 2017—now part of McKinsey Design. Outside of McKinsey, Martin is a trustee on the board of Asia House in London.
Published work
“Winning against COVID-19: The implications for biopharma,” McKinsey & Company, April 2020
“Harnessing automation for a future that works,” McKinsey Global Institute, January 2017
“Manager and machine: The new leadership equation,” McKinsey Quarterly, September 2014
“Building the social enterprise,” McKinsey Quarterly, November 2013
“How multinationals can attract the talent they need,” McKinsey Quarterly, June 2012
“Managing at global scale,” McKinsey Quarterly, June 2012
“The global company’s challenges,” McKinsey Quarterly, June 2012
“Understanding your 'globalization penalty,'”McKinsey Quarterly, July 2011
Education
INSEAD, France
MBA
Magdalen College, Oxford University
BA, history